98%
921
2 minutes
20
Oral squamous cell carcinoma (OSCC) of the tongue is a common type of head and neck malignancy with a poor prognosis, underscoring the urgency for early detection. MicroRNAs (miRNAs) have remarkable stability and are easily measurable. Thus, miRNAs may be a promising biomarker candidate among biomarkers in cancer diagnosis. Biomarkers have the potential to facilitate personalized medicine approaches by guiding treatment decisions and optimizing therapy regimens for individual patients. Utilizing data from The Cancer Genome Atlas, we identified 13 differentially expressed upregulated miRNAs in OSCC of the tongue. Differentially expressed miRNAs were analyzed by enrichment analysis to reveal underlying biological processes, pathways, or functions. Furthermore, we identified miRNAs associated with the progression of OSCC of the tongue, utilizing receiver operating characteristic analysis to evaluate their potential as diagnostic biomarkers. A total of 13 upregulated miRNAs were identified as differentially expressed in OSCC of the tongue. Five of these miRNAs had high diagnostic power. In particular, miR-196b has the potential to serve as one of the most effective diagnostic biomarkers. Then, functional enrichment analysis for the target gene of miR-196b was performed, and a protein-protein interaction network was constructed. This study assessed an effective approach for identifying miRNAs as early diagnostic markers for OSCC of the tongue.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11276561 | PMC |
http://dx.doi.org/10.3390/cimb46070402 | DOI Listing |
Cureus
August 2025
Division of Oral and Maxillofacial Surgery, Faculty of Dentistry and Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JPN.
Objective Patients with oral squamous cell carcinoma (OSCC) may choose best supportive care (BSC) as initial treatment over active treatment for several reasons. However, no previous reports have compared the clinical characteristics of OSCC patients opting for BSC as initial treatment with those receiving standard treatment. This study retrospectively analyzed these differences to identify the factors influencing this decision.
View Article and Find Full Text PDFHead Neck
September 2025
Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Background: Three-dimensional (3D) modeling has been used in the management of bony head and neck tumors, but not in soft tissue tumors. Currently, histopathological findings of oral squamous cell carcinomas (OSCC) are presented as two-dimensional images. Previously, we developed a 3D image fusion method that presents tumor histopathology and MRI in 3D form.
View Article and Find Full Text PDFSci Rep
September 2025
Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
The incidence of oropharyngeal cancers is increasing due to human papilloma virus (HPV); however, this phenomenon does not explain the rising incidence of oral cancers, for which the reason remains unknown. These cancers are typically diagnosed at an advanced stage, which adversely affects the prognosis. Improved methods for early detection, such as blood-based biomarkers, could significantly improve patient outcomes.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Computer Science, Hanyang University, Seoul, 04763, South Korea.
This study aimed to develop and evaluate deep convolutional neural network (DCNN) models with Grad-CAM visualization for the automated classification with interpretability of tongue conditions-specifically glossitis and oral squamous cell carcinoma (OSCC)-using clinical tongue photographs, with a focus on their potential for early detection and telemedicine-based diagnostics. A total of 652 tongue images were categorized into normal control (n = 294), glossitis (n = 340), and OSCC (n = 17). Four pretrained DCNN architectures (VGG16, VGG19, ResNet50, ResNet152) were fine-tuned using transfer learning.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Pathology, Tokyo Dental College, Tokyo, Japan.
Studies have indicated moderate to high choline transporter-like protein 1 (CTL1) expression in colon, pancreatic, breast, lung, and glioma cancers. However, studies on CTL1 in oral squamous cell carcinoma (OSCC), a highly invasive cancer, remain limited. We aimed to investigate the expression and localization of CTL1 in OSCC and its association with cell proliferation.
View Article and Find Full Text PDF